Develops drugs for skin cancers and molluscum.
Jun 2026Revenue $30.3M/yrExpenses $58.7M/yr
No trendCash runway ≈ 10 months from Jun 2026
Figures by year
When will Verrica Pharmaceuticals be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $30.3M and expenses $58.7M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $35.6M | $47.8M | −$12.2M |
| Dec 2024 | $7.57M | $73.5M | −$65.9M |
| Dec 2023 | $5.12M | $70.9M | −$65.8M |
| Dec 2022 | $9.03M | $30.3M | −$21.3M |
| Dec 2021 | $12.0M | $42.9M | −$30.9M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.